Literature DB >> 21951985

Alzheimer's disease: implications of the updated diagnostic and research criteria.

Eric M Reiman1, Guy M McKhann, Marilyn S Albert, Reisa A Sperling, Ronald C Petersen, Deborah Blacker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21951985      PMCID： PMC4068242          DOI： 10.4088/JCP.10087co1c

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN： 0160-6689            Impact factor:   4.384


× No keyword cloud information.
  12 in total

1.  The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Guy M McKhann; David S Knopman; Howard Chertkow; Bradley T Hyman; Clifford R Jack; Claudia H Kawas; William E Klunk; Walter J Koroshetz; Jennifer J Manly; Richard Mayeux; Richard C Mohs; John C Morris; Martin N Rossor; Philip Scheltens; Maria C Carrillo; Bill Thies; Sandra Weintraub; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

2.  Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Clifford R Jack; Marilyn S Albert; David S Knopman; Guy M McKhann; Reisa A Sperling; Maria C Carrillo; Bill Thies; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

3.  The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Marilyn S Albert; Steven T DeKosky; Dennis Dickson; Bruno Dubois; Howard H Feldman; Nick C Fox; Anthony Gamst; David M Holtzman; William J Jagust; Ronald C Petersen; Peter J Snyder; Maria C Carrillo; Bill Thies; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

Review 4.  Mild cognitive impairment.

Authors:  Serge Gauthier; Barry Reisberg; Michael Zaudig; Ronald C Petersen; Karen Ritchie; Karl Broich; Sylvie Belleville; Henry Brodaty; David Bennett; Howard Chertkow; Jeffrey L Cummings; Mony de Leon; Howard Feldman; Mary Ganguli; Harald Hampel; Philip Scheltens; Mary C Tierney; Peter Whitehouse; Bengt Winblad
Journal:  Lancet       Date:  2006-04-15       Impact factor: 79.321

5.  Mild cognitive impairment should be considered for DSM-V.

Authors:  Ronald C Petersen; John O'Brien
Journal:  J Geriatr Psychiatry Neurol       Date:  2006-09       Impact factor: 2.680

6.  Comparing predictors of conversion and decline in mild cognitive impairment.

Authors:  S M Landau; D Harvey; C M Madison; E M Reiman; N L Foster; P S Aisen; R C Petersen; L M Shaw; J Q Trojanowski; C R Jack; M W Weiner; W J Jagust
Journal:  Neurology       Date:  2010-06-30       Impact factor: 9.910

7.  Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials.

Authors:  Michael Grundman; Ronald C Petersen; Steven H Ferris; Ronald G Thomas; Paul S Aisen; David A Bennett; Norman L Foster; Clifford R Jack; Douglas R Galasko; Rachelle Doody; Jeffrey Kaye; Mary Sano; Richard Mohs; Serge Gauthier; Hyun T Kim; Shelia Jin; Arlan N Schultz; Kimberly Schafer; Ruth Mulnard; Christopher H van Dyck; Jacobo Mintzer; Edward Y Zamrini; Deborah Cahn-Weiner; Leon J Thal
Journal:  Arch Neurol       Date:  2004-01

8.  Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia.

Authors:  Eric E Smith; Svetlana Egorova; Deborah Blacker; Ronald J Killiany; Alona Muzikansky; Bradford C Dickerson; Rudolph E Tanzi; Marilyn S Albert; Steven M Greenberg; Charles R G Guttmann
Journal:  Arch Neurol       Date:  2008-01

9.  Revising the definition of Alzheimer's disease: a new lexicon.

Authors:  Bruno Dubois; Howard H Feldman; Claudia Jacova; Jeffrey L Cummings; Steven T Dekosky; Pascale Barberger-Gateau; André Delacourte; Giovanni Frisoni; Nick C Fox; Douglas Galasko; Serge Gauthier; Harald Hampel; Gregory A Jicha; Kenichi Meguro; John O'Brien; Florence Pasquier; Philippe Robert; Martin Rossor; Steven Salloway; Marie Sarazin; Leonardo C de Souza; Yaakov Stern; Pieter J Visser; Philip Scheltens
Journal:  Lancet Neurol       Date:  2010-10-09       Impact factor: 44.182

10.  Using functional Magnetic Resonance Imaging to differentiate between healthy aging subjects, Mild Cognitive Impairment, and Alzheimer's patients.

Authors:  Mohammad Ali Oghabian; Seyed Amir Hossein Batouli; Maryam Norouzian; Maryam Ziaei; Hajir Sikaroodi
Journal:  J Res Med Sci       Date:  2010-03       Impact factor: 1.852
View more
  18 in total

1.  Current guidelines for dementia screening: shortcomings and recommended changes.

Authors:  Magdalena I Tolea; James E Galvin
Journal:  Neurodegener Dis Manag       Date:  2013-12

2.  Biomarkers of basic activities of daily living in Alzheimer's disease.

Authors:  James R Hall; Leigh A Johnson; Robert C Barber; Hoa T Vo; A Scott Winter; Sid E O'Bryant
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

3.  Clinical implications of the new diagnostic guidelines for dementia.

Authors:  Edmund Howe
Journal:  Innov Clin Neurosci       Date:  2013-05

4.  Effect of common neuropathologies on progression of late life cognitive impairment.

Authors:  Lei Yu; Patricia A Boyle; Sue Leurgans; Julie A Schneider; Richard J Kryscio; Robert S Wilson; David A Bennett
Journal:  Neurobiol Aging       Date:  2015-04-22       Impact factor: 4.673

5.  The National Institute on Aging-Alzheimer's Association research criteria for mild cognitive impairment due to Alzheimer's disease: predicting the outcome.

Authors:  Liang-Hao Guo; Panagiotis Alexopoulos; Tamara Eisele; Stefan Wagenpfeil; Alexander Kurz; Robert Perneczky
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-08-30       Impact factor: 5.270

Review 6.  Insulin resistance in Alzheimer's disease.

Authors:  Kelly T Dineley; Jordan B Jahrling; Larry Denner
Journal:  Neurobiol Dis       Date:  2014-09-16       Impact factor: 5.996

7.  Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need.

Authors:  Ganesh M Babulal; Yakeel T Quiroz; Benedict C Albensi; Eider Arenaza-Urquijo; Arlene J Astell; Claudio Babiloni; Alex Bahar-Fuchs; Joanne Bell; Gene L Bowman; Adam M Brickman; Gaël Chételat; Carrie Ciro; Ann D Cohen; Peggye Dilworth-Anderson; Hiroko H Dodge; Simone Dreux; Steven Edland; Anna Esbensen; Lisbeth Evered; Michael Ewers; Keith N Fargo; Juan Fortea; Hector Gonzalez; Deborah R Gustafson; Elizabeth Head; James A Hendrix; Scott M Hofer; Leigh A Johnson; Roos Jutten; Kerry Kilborn; Krista L Lanctôt; Jennifer J Manly; Ralph N Martins; Michelle M Mielke; Martha Clare Morris; Melissa E Murray; Esther S Oh; Mario A Parra; Robert A Rissman; Catherine M Roe; Octavio A Santos; Nikolaos Scarmeas; Lon S Schneider; Nicole Schupf; Sietske Sikkes; Heather M Snyder; Hamid R Sohrabi; Yaakov Stern; Andre Strydom; Yi Tang; Graciela Muniz Terrera; Charlotte Teunissen; Debora Melo van Lent; Michael Weinborn; Linda Wesselman; Donna M Wilcock; Henrik Zetterberg; Sid E O'Bryant
Journal:  Alzheimers Dement       Date:  2018-12-13       Impact factor: 21.566

8.  Successful Scene Encoding in Presymptomatic Early-Onset Alzheimer's Disease.

Authors:  Yakeel T Quiroz; Kim Celone Willment; Gabriel Castrillon; Martha Muniz; Francisco Lopera; Andrew Budson; Chantal E Stern
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

9.  Evaluation of the Reliability, Validity, and Predictive Validity of the Subscales of the Perceived Stress Scale in Older Adults.

Authors:  Julie M Jiang; Elizabeth K Seng; Molly E Zimmerman; Martin Sliwinski; Mimi Kim; Richard B Lipton
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 10.  Induced pluripotent stem cells to model and treat neurogenetic disorders.

Authors:  Hansen Wang; Laurie C Doering
Journal:  Neural Plast       Date:  2012-07-19       Impact factor: 3.599
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.